| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |